Frieder Hänisch

Dr. Frieder Hänisch is an experienced scientific leader and management executive, currently serving as the Head of Department Hospital Laboratory Management at MVZ Labor Dr. Limbach & Kollegen. 

Prior to this position, Dr. Hänisch built a robust portfolio in healthcare and biotechnology management. He served in project management and business development capacities across the Limbach Group, including roles as Project Manager at MVZ Labor Schweinfurt GmbH and Business Development Manager for Limbach Group SE. Additionally, he demonstrated early leadership in the global biotech community as the Chief Operating Officer and Strategy & IT Director at Global Biotech Revolution C.I.C., where he notably co-organized GapSummit 2014, the first intergenerational leadership summit in biotechnology.

Dr. Hänisch’s strategic management career is built upon a highly distinguished academic and scientific foundation. He earned his PhD from the University of Cambridge, conducting EPSRC-funded research on identifying a proteomic biomarker signature in bipolar affective disorder. This pioneering research led to a 2015 European patent filing for a blood-based diagnostic panel for bipolar disorder. He has co-authored numerous peer-reviewed publications in high-impact journals, including Translational Psychiatry, Molecular Psychiatry, and Brain, Behavior, and Immunity. He also holds a Master of Science in Genome-based Systems Biology and a Bachelor of Science in Molecular Biotechnology from Bielefeld University. During his time at Bielefeld, he founded and led the university's first iGEM team, earning a prestigious gold medal from the Massachusetts Institute of Technology (MIT).